Evaluation of microbial products for the control of zucchini foot and root rot caused by Fusarium solani f. sp. cucurbitae race 1

Microbial products containing bacteria (Cedomon [Pseudomonas chlororaphis MA342, PC-MA342], Mycostop [Streptomyces sp. K61, SG-K61], Proradix®Agro [Pseudomonas sp. DSMZ13134, PS-DSMZ13134]) and fungi (Clonotry [Trichoderma harzianum and Clonostachys rosea, TH+CR], Remedier [T. asperellum ICC012 and T. gamsii ICC080, TA-ICC012+TG-ICC080], Rootshield WP [T. harzianum T22, TH-T22]) were tested for efficacy against Fusarium solani f. sp. cucurbitae race 1 (FSC7 strain) on zucchini. They were applied to seeds (S), plant growth substrate (PGS) and both (S+PGS) in a growth chamber experiment, and to PGS, transplantation soil mixture (TSM) and both (PGS+TSM) in a greenhouse experiment. FSC7 was inoculated in PGS at sowing time in the growth chamber and in TSM at transplant in the greenhouse. In the growth chamber, the most effective products were Cedomon (S and S+PGS treatments), Rootshield (PGS treatment) and Proradix (S+PGS treatment), reducing the disease by 39.7, 43.1, 25.8 and 36.4%, respectively. In the greenhouse, all tested products applied to PGS reduced the disease severity and more markedly when applied to PGS+TSM. In the PGS and PGS+TSM treatments, Cedomon was the most effective product showing a disease decrease by 42.4 and 59.5%, respectively. The data obtained in vivo were consistent with the ability of the antagonists to colonize zucchini rhizosphere and with their inhibitory effects on the growth of the pathogen in in vitro assays. The bacteria caused the greatest growth inhibition of FSC7 showing abnormal morphology, while Trichoderma spp. parasitized FSC7 hyphae. Bacteria were the most active in reducing pathogen colony growth through antibiotic metabolites. All antagonists produced exo and endochitinase enzymes. Trichoderma strains showed greater levels of β-N-acetylhexosaminidase and endochitinase, whereas SG-K61 was the most active producer of chitin 1,4-β-chitobiosidase. These results indicate that the studied bioproducts have potential for an effective management of zucchini Fusarium foot and root rot through rhizosphere competence and several mechanisms exerted by their microbial ingredients

Evaluation of microbial products for the control of zucchini foot and root rot caused by Fusarium solani f. sp. cucurbitae race 1

Microbial products containing bacteria (Cedomon [Pseudomonas chlororaphis MA342, PC-MA342], Mycostop [Streptomyces sp. K61, SG-K61], Proradix®Agro [Pseudomonas sp. DSMZ13134, PS-DSMZ13134]) and fungi (Clonotry [Trichoderma harzianum and Clonostachys rosea, TH+CR], Remedier [T. asperellum ICC012 and T. gamsii ICC080, TA-ICC012+TG-ICC080], Rootshield WP [T. harzianum T22, TH-T22]) were tested for efficacy against Fusarium solani f. sp. cucurbitae race 1 (FSC7 strain) on zucchini. They were applied to seeds (S), plant growth substrate (PGS) and both (S+PGS) in a growth chamber experiment, and to PGS, transplantation soil mixture (TSM) and both (PGS+TSM) in a greenhouse experiment. FSC7 was inoculated in PGS at sowing time in the growth chamber and in TSM at transplant in the greenhouse. In the growth chamber, the most effective products were Cedomon (S and S+PGS treatments), Rootshield (PGS treatment) and Proradix (S+PGS treatment), reducing the disease by 39.7, 43.1, 25.8 and 36.4%, respectively. In the greenhouse, all tested products applied to PGS reduced the disease severity and more markedly when applied to PGS+TSM. In the PGS and PGS+TSM treatments, Cedomon was the most effective product showing a disease decrease by 42.4 and 59.5%, respectively. The data obtained in vivo were consistent with the ability of the antagonists to colonize zucchini rhizosphere and with their inhibitory effects on the growth of the pathogen in in vitro assays. The bacteria caused the greatest growth inhibition of FSC7 showing abnormal morphology, while Trichoderma spp. parasitized FSC7 hyphae. Bacteria were the most active in reducing pathogen colony growth through antibiotic metabolites. All antagonists produced exo- and endochitinase enzymes. Trichoderma strains showed greater levels of β-N-acetylhexosaminidase and endochitinase, whereas SG-K61 was the most active producer of chitin 1,4-β-chitobiosidase. These results indicate that the studied bioproducts have potential for an effective management of zucchini Fusarium foot and root rot through rhizosphere competence and several mechanisms exerted by their microbial ingredients

SEM Investigation about Hyphal Relationships between Some Antagonistic Fungi against «Fusarium» spp. Foot Rot Pathogen of Wheat

Wheat foot rot caused by Fusarium species is a worldwide wheat disease against which the use of biocontrol agents is of increasing interest. Mycoparasitic activities of a strain of five antagonistic fungi, Gliocladium roseum (GR11), Penicillium frequentans (PF), Trichoderma atroviride (TA312), T. longibrachiatum (TL9) and T. harzianum (TH144), against three pathogens, Fusarium culmorum, F. graminearum and F. nivale, were studied by scanning electron microscopy (SEM). SEM observations suggested that the outcome of interaction between antagonist and pathogen occurred when intimate contact was established between hyphae triggering a series of events in pathogen degradation. The interaction between Trichoderma spp. and Fusarium spp. revealed that the mycoparasitic hyphae were usually attached longitudinally to the hyphae of the pathogens; hyphal coilings, hooks, pincer-shaped structures, short contact branches and hyphal depressions were also present. GR11 and PF hyphae grew mainly parallel to the pathogen causing its hyphal depression. The parasitic action of the antagonists shown with the formation of pincers, hooks and other structures leading to cell disruption, goes some way towards explaining their mode of action in the biological control of the pathogens studied

Characterization of the complex locus of bean encoding polygalacturonase-inhibiting proteins reveals subfunctionalization for defense against fungi and insects.

Polygalacturonase-inhibiting proteins (PGIPs) are extracellular plant inhibitors of fungal endopolygalacturonases (PGs) that belong to the superfamily of Leu-rich repeat proteins. We have characterized the full complement of pgip genes in the bean (Phaseolus vulgaris) genotype BAT93. This comprises four clustered members that span a 50-kb region and, based on their similarity, form two pairs (Pvpgip1/Pvpgip2 and Pvpgip3/Pvpgip4). Characterization of the encoded products revealed both partial redundancy and subfunctionalization against fungal-derived PGs. Notably, the pair PvPGIP3/PvPGIP4 also inhibited PGs of two mirid bugs (Lygus rugulipennis and Adelphocoris lineolatus). Characterization of Pvpgip genes of Pinto bean showed variations limited to single synonymous substitutions or small deletions. A three-amino acid deletion encompassing a residue previously identified as crucial for recognition of PG of Fusarium moniliforme was responsible for the inability of BAT93 PvPGIP2 to inhibit this enzyme. Consistent with the large variations observed in the promoter sequences, reverse transcription-PCR expression analysis revealed that the different family members differentially respond to elicitors, wounding, and salicylic acid. We conclude that both biochemical and regulatory redundancy and subfunctionalization of pgip genes are important for the adaptation of plants to pathogenic fungi and phytophagous insects

Effects of grapevine applications of fosetyl-aluminium formulations for downy mildew control on “esca” and associated fungi

Esca of grapevine is a fungal disease with a complex aetiology that is common in almost all regions of the world where grapes are cultivated. Despite much research, no effective control of the disease has been found. We investigated possible activity of fosetyl-aluminium (fosetyl-Al), an active ingredient in many fungicides against downy mildew, to inhibit development of esca in grapevine and the main pathogens linked to the disease, Phaeomoniella chlamydospora (Pch) and Phaeoacremonium aleophilum (Pal). In greenhouse experiments conducted on vines artificially inoculated with Pch or Pal, we found a reduction in necrosis in the woody tissue. In field experiments conducted over several years statistically significant reductions in the annual and cumulative incidence of the disease symptoms, and in cumulative vine mortality, were seen. The effect of fosetyl-Al treatments on leaf gas exchange, levels of resveratrol and å-viniferin in the wood, and enzymatic activities were also studied. Hypotheses regarding the mechanism of action of fosetyl-Al against esca are outlined, and the possible use of products containing the chemical, applied on foliage to control downy mildew, is discussed as a strategy for control of esca

A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study

Objective: There are few comparative data on the third-generation antiseizure medications (ASMs). We aimed to assess and compare the effectiveness of brivaracetam (BRV), eslicarbazepine acetate (ESL), lacosamide (LCM), and perampanel (PER) in people with epilepsy (PWE). Efficacy and tolerability were compared as secondary objectives.Methods: This multicenter, retrospective study collected data from 22 Italian neurology/epilepsy centers. All adult PWE who started add-on treatment with one of the studied ASMs between January 2018 and October 2021 were included. Retention rate was established as effectiveness measure and described using Kaplan-Meier curves and the best fitting survival model. The responder status and the occurrence of adverse events (AEs) were used to evaluate efficacy and safety, respectively. The odds of AEs and drug efficacy were estimated by two multilevel logistic models.Results: A total of 960 patients (52.92% females, median age = 43 years) met the inclusion criteria. They mainly suffered from structural epilepsy (52.29%) with monthly (46.2%) focal seizures (69.58%). Compared with LCM, all the studied ASMs had a higher dropout risk, statistically significant in the BRV levetiracetam (LEV)-na & iuml;ve (hazard ratio [HR] = 1.97, 95% confidence interval [CI] = 1.17-3.29) and PER groups (HR = 1.64, 95% CI = 1.06-2.55). Women were at higher risk of discontinuing ESL (HR = 5.33, 95% CI = 1.71-16.61), as well as PER-treated patients with unknown epilepsy etiology versus those with structural etiology (HR = 1.74, 95% CI = 1.05-2.88). BRV with prior LEV therapy showed lower odds of efficacy (odds ratio [OR] = .08, 95% CI = .01-.48) versus LCM, whereas a higher efficacy was observed in women treated with BRV and LEV-na & iuml;ve (OR = 10.32, 95% CI = 1.55-68.78) versus men. PER (OR = 6.93, 95% CI = 3.32-14.44) and BRV in LEV-na & iuml;ve patients (OR = 6.80, 95% CI = 2.64-17.52) had a higher chance of AEs than LCM.Significance: Comparative evidence from real-world studies may help clinicians to tailor treatments according to patients' demographic and clinical characteristics

Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia

Abstract Background Sensorineural hearing loss in beta-thalassemia is common and it is generally associated with iron chelation therapy. However, data are scarce, especially on adult populations, and a possible involvement of the central auditory areas has not been investigated yet. We performed a multicenter cross-sectional audiological and single-center 3Tesla brain perfusion MRI study enrolling 77 transfusion-dependent/non transfusion-dependent adult patients and 56 healthy controls. Pure tone audiometry, demographics, clinical/laboratory and cognitive functioning data were recorded. Results Half of patients (52%) presented with high-frequency hearing deficit, with overt hypoacusia (Pure Tone Average (PTA) > 25 dB) in 35%, irrespective of iron chelation or clinical phenotype. Bilateral voxel clusters of significant relative hypoperfusion were found in the auditory cortex of beta-thalassemia patients, regardless of clinical phenotype. In controls and transfusion-dependent (but not in non-transfusion-dependent) patients, the relative auditory cortex perfusion values increased linearly with age (p < 0.04). Relative auditory cortex perfusion values showed a significant U-shaped correlation with PTA values among hearing loss patients, and a linear correlation with the full scale intelligence quotient (right side p = 0.01, left side p = 0.02) with its domain related to communication skills (right side p = 0.04, left side p = 0.07) in controls but not in beta-thalassemia patients. Audiometric test results did not correlate to cognitive test scores in any subgroup. Conclusions In conclusion, primary auditory cortex perfusion changes are a metabolic hallmark of adult beta-thalassemia, thus suggesting complex remodeling of the hearing function, that occurs regardless of chelation therapy and before clinically manifest hearing loss. The cognitive impact of perfusion changes is intriguing but requires further investigations

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort

Transfusion-dependent patients typically develop iron-induced cardiomyopathy, liver disease, and endocrine complications. We aimed to estimate the incidence of endocrine disorders in transfusion-dependent thalassemia (TDT) patients during long-term iron-chelation therapy with deferasirox (DFX).We developed a multicentre follow-up study of 426 TDT patients treated with once-daily DFX for a median duration of 8 years, up to 18.5 years. At baseline, 118, 121, and 187 patients had 0, 1, or ≥2 endocrine diseases respectively. 104 additional endocrine diseases were developed during the follow-up. The overall risk of developing a new endocrine complication within 5 years was 9.7% (95%CI=6.3-13.1). Multiple Cox regression analysis identified 3 key predictors: age showed a positive log-linear effect (adjusted HR for 50% increase=1.2, 95%CI=1.1-1.3, P=0.005), the serum concentration of thyrotropin (TSH) showed a positive linear effect (adjusted HR for 1 mIU/L increase=1.3, 95%CI=1.1-1.4, P